Could Ketamine Become a Contender for Short-Term Depression Treatment?
Ketamine is a unique injectable anesthetic that has to be prescribed and is only available to physicians; it is often used as a general anesthetic for children, persons of poor health and in veterinary medicine. Ketamine belongs to a class of drugs called “dissociative anesthetics, which separate perception from sensation; other drugs in this class are PCP and nitrous oxide (laughing gas). Recently the drug was utilized as a short term treatment of depression in a clinical trial revealing that only about a third of patients achieved good results, even after good optimal therapy. Although Ketamine was shown to relieve severe/ treatment- resistant depression, the application was painful and the results only lasted a few hours/ days. Once the drug’s effects wore off, the initial depression appeared to be more intense and heavily concentrated on negativism.
Although, Ketamine is a Food and Drug Administration approved medication and any medical doctor could prescribe the substance, no one has been willing/ perceptive to administering it. It is becoming the new high for teens and being referred to as “Special K” because of the trippy effect it radiates in allowing the users to feel away from reality and their bodies. It also allows users to enter a state called “K-Hole” that allows a near death experience that allows one to feel an out of body occurrence, while immobilizing the body through muscle impairment. Side effects of Ketamine are increased heart rate, disruptions in consciousness and substance addiction.
If you or anyone you know is currently suffering negatively from the influence of the product Ketamine, take action to encourage them to seek the help that they deserve before the downward effects take a toll on their lifestyle/ well being.